pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Ebola vaccine
drug
save

Ebola vaccine

Preclinicalupdated 5mo ago
by $SNGX SOLIGENIX, INC.
Preclinical
community read0 votes

all catalysts(0)

nothing on the calendar yet

News(10)

  • At a federal autism advisory committee meeting, members double down on long-debunked theories
    RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from Morning Rounds
    stat · 1mo ago
  • Decoding DEA action on kratom-related substances
    RFK Jr. downplays measles threat, FDA approves pancreatic drug, and more health news from Morning Rounds
    stat · 1mo ago
  • CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
    The Coalition for Epidemic Preparedness Innovations has committed up to $16.5 million to push Minapharm’s Bundibugyo vaccine candidate into the clinic, furthering its response to the Ebola outbreak.
    fiercebiotech · 1mo ago
  • Even at big companies, health care costs are increasing
    Two U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news today
    stat · 1mo ago
  • CDC releases latest life expectancy data
    Deleted public comments on White House proposals, how Trump cuts are reshaping rural health care, and more Morning Rounds news
    stat · 1mo ago
  • FDA plans to regulate generative AI
    New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds
    stat · 1mo ago
  • Scientists deploy Merck’s Ebola vaccine in DRC
    Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds
    stat · 1mo ago
  • Opinion: I’ve seen what life is like without vaccines. Americans need to understand what they save us from
    “The ability to prevent a deadly infectious disease is an extraordinary privilege,” writes infectious disease physician Krutika Kuppalli.
    stat · 1mo ago
  • Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
    Talks are underway between the Democratic Republic of the Congo and the WHO to expedite the start of a multi-armed Phase 3 clinical trial of Ebola vaccines.
    stat · 1mo ago
  • The main therapy used for children with autism faces changes under Medicaid
    Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
    stat · 1mo ago
view all news mentions →
indication
Ebolavirus Infections (Ebola Hemorrhagic Fever)
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?